LEADER 01276nam  2200373 a 450 
001 9910701738403321
005 20120501114552.0
035   $a(CKB)5470000002420715
035   $a(OCoLC)792819335
035   $a(EXLCZ)995470000002420715
100   $a20120501d2003      ua             0
101 0 $aeng
135   $aurbn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aFDA Counterfeit Drug Task Force interim report$b[electronic resource] $esafe & secure
210  1$aRockville, Md. :$cU.S. Dept. of Health and Human Services, Food and Drug Administration,$d[2003]
215   $a1 online resource (ii, 40 pages) $cillustrations
300   $aTitle from title screen (viewed on May 1, 2012).
300   $a"October 2003."
517   $aFDA Counterfeit Drug Task Force interim report 
606   $aProduct counterfeiting$zUnited States
606   $aDrugs$xStandards$zUnited States
606   $aDrug adulteration$zUnited States
615  0$aProduct counterfeiting
615  0$aDrugs$xStandards
615  0$aDrug adulteration
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910701738403321
996   $aFDA Counterfeit Drug Task Force interim report$93484765
997   $aUNINA